Literature DB >> 12089560

Regulation of endogenous gene expression with a small-molecule dimerizer.

Roy Pollock1, Maryann Giel, Katja Linher, Tim Clackson.   

Abstract

Artificial transcription factors containing designer zinc-finger DNA-binding domains (DBDs) have been used to activate or repress expression of a growing number of endogenous genes. We have combined targeted zinc-finger DBD technology with a dimerizer-regulated gene expression system to permit the small-molecule control of endogenous gene transcription. We constructed a dimerizer-responsive transcription factor that incorporates an artificial zinc-finger DBD targeted to the promoter of the human VEGF gene. Introduction of this activator into human cells allowed expression of the chromosomal VEGF gene to be induced by a small-molecule dimerizer compound consisting of a nonimmunosuppressive rapamycin analog. We found that by directly regulating zinc-finger protein (ZFP) activity, we could circumvent difficulties encountered in the generation of cell lines stably expressing conventional unregulated activators. Dimerizer-dependent VEGF induction was rapid, tight, and dose dependent, and resulted in VEGF protein expression levels several-fold greater than those produced by the natural hypoxic response.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12089560     DOI: 10.1038/nbt0702-729

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  25 in total

Review 1.  Therapeutic modulation of endogenous gene function by agents with designed DNA-sequence specificities.

Authors:  Taco G Uil; Hidde J Haisma; Marianne G Rots
Journal:  Nucleic Acids Res       Date:  2003-11-01       Impact factor: 16.971

2.  Small molecule control of pre-mRNA splicing.

Authors:  Brenton R Graveley
Journal:  RNA       Date:  2005-01-20       Impact factor: 4.942

3.  Drug-inducible and simultaneous regulation of endogenous genes by single-chain nuclear receptor-based zinc-finger transcription factor gene switches.

Authors:  L Magnenat; L J Schwimmer; C F Barbas
Journal:  Gene Ther       Date:  2008-06-05       Impact factor: 5.250

4.  Induced Dimerization Tools to Deplete Specific Phosphatidylinositol Phosphates.

Authors:  Jonathan Pacheco; Rachel C Wills; Gerald R V Hammond
Journal:  Methods Mol Biol       Date:  2021

Review 5.  Genome-Editing Technologies: Principles and Applications.

Authors:  Thomas Gaj; Shannon J Sirk; Sai-Lan Shui; Jia Liu
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-12-01       Impact factor: 10.005

6.  Patterning expression of regenerative growth factors using high intensity focused ultrasound.

Authors:  Christopher G Wilson; Francisco M Martín-Saavedra; Frédéric Padilla; Mario L Fabiilli; Man Zhang; Alexander M Baez; Christopher J Bonkowski; Oliver D Kripfgans; Richard Voellmy; Nuria Vilaboa; J Brian Fowlkes; Renny T Franceschi
Journal:  Tissue Eng Part C Methods       Date:  2014-03-11       Impact factor: 3.056

7.  Inhibition of herpes simplex virus 1 gene expression by designer zinc-finger transcription factors.

Authors:  Monika Papworth; Michael Moore; Mark Isalan; Michal Minczuk; Yen Choo; Aaron Klug
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-06       Impact factor: 11.205

8.  Spatiotemporal control of vascular endothelial growth factor expression using a heat-shock-activated, rapamycin-dependent gene switch.

Authors:  Francisco M Martín-Saavedra; Christopher G Wilson; Richard Voellmy; Nuria Vilaboa; Renny T Franceschi
Journal:  Hum Gene Ther Methods       Date:  2013-05-06       Impact factor: 2.396

9.  Characterization of a molecular switch system that regulates gene expression in mammalian cells through a small molecule.

Authors:  Jennifer L Taylor; Priyanka Rohatgi; H Trent Spencer; Donald F Doyle; Bahareh Azizi
Journal:  BMC Biotechnol       Date:  2010-02-18       Impact factor: 2.563

Review 10.  Zinc finger nucleases as tools to understand and treat human diseases.

Authors:  David Davis; David Stokoe
Journal:  BMC Med       Date:  2010-07-01       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.